Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 1 | Journal of Inflammation

Fig. 1

From: Bullatacin triggers immunogenic cell death of colon cancer cells by activating endoplasmic reticulum chaperones

Fig. 1

Bullatacin induces apoptosis in colon cancer cells. A CCK-8 assay of the cell viability of SW480 cells treated with bullatacin for 24 h. Significance: **P < 0.01 versus control. B CCK-8 assay of the cell viability of HT-29 cells treated with bullatacin for 24 h. Significance: **P < 0.01 versus control. C Flow cytometric analysis of the time-dependent apoptosis of SW480 cells treated with bullatacin (10 nM). D Flow cytometric analysis of the time-dependent apoptosis of HT-29 cells treated with bullatacin (10 nM)

Back to article page

Journal of Inflammation

ISSN: 1476-9255

Contact us